CALM vs. BSX
CALM (Cal-Maine Foods, Inc.) and BSX (Boston Scientific Corporation) are both stocks. CALM operates in Farm Products (Consumer Defensive), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, CALM returned 9.13%/yr vs 7.78%/yr for BSX. At a 0.13 correlation, their price movements are largely independent.
Performance
CALM vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CALM achieves a -2.78% return, which is significantly higher than BSX's -48.93% return. Over the past 10 years, CALM has outperformed BSX with an annualized return of 9.13%, while BSX has yielded a comparatively lower 7.78% annualized return.
CALM
- 1D
- 0.91%
- 1M
- 0.33%
- YTD
- -2.78%
- 6M
- -9.32%
- 1Y
- -18.13%
- 3Y*
- 21.90%
- 5Y*
- 21.90%
- 10Y*
- 9.13%
BSX
- 1D
- 0.31%
- 1M
- -9.70%
- YTD
- -48.93%
- 6M
- -48.10%
- 1Y
- -52.30%
- 3Y*
- -1.71%
- 5Y*
- 2.84%
- 10Y*
- 7.78%
CALM vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CALM Cal-Maine Foods, Inc. | -2.78% | -15.61% | 87.00% | 14.48% | 51.87% | -1.38% | -12.19% | 2.09% | -3.90% | 0.62% |
BSX Boston Scientific Corporation | -48.93% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between CALM and BSX is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Dec 13, 1996 | 0.13 |
The correlation between CALM and BSX shifts across timeframes, from -0.04 (1 year) to 0.13 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CALM:
$3.62B
BSX:
$72.81B
CALM:
$14.48
BSX:
$2.38
CALM:
5.27
BSX:
20.49
CALM:
0.00
BSX:
0.46
CALM:
1.06
BSX:
3.53
CALM:
1.34
BSX:
2.81
CALM:
$3.46B
BSX:
$20.62B
CALM:
$1.17B
BSX:
$14.52B
CALM:
$1.05B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CALM vs. BSX — Risk / Return Rank
CALM
BSX
CALM vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cal-Maine Foods, Inc. (CALM) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CALM | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.96 | ||
| Sortino ratioReturn per unit of downside risk | +1.64 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 0.67 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | -0.94 | +0.45 |
| Martin ratioReturn relative to average drawdown | -0.77 | -2.07 | +1.30 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CALM | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.55 | -1.51 | +0.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.68 | 0.11 | +0.56 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.29 | +0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.20 | +0.18 |
Drawdowns
CALM vs. BSX - Drawdown Comparison
The maximum CALM drawdown since its inception was -74.08%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for CALM and BSX.
Loading charts...
Drawdown Indicators
| CALM | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.08% | -89.15% | +15.07% |
Max Drawdown (1Y)Largest decline over 1 year | -37.00% | -55.91% | +18.91% |
Max Drawdown (3Y)Largest decline over 3 years | -37.00% | -55.91% | +18.91% |
Max Drawdown (5Y)Largest decline over 5 years | -37.00% | -55.91% | +18.91% |
Max Drawdown (10Y)Largest decline over 10 years | -39.12% | -55.91% | +16.79% |
Current DrawdownCurrent decline from peak | -32.72% | -54.97% | +22.25% |
Average DrawdownAverage peak-to-trough decline | -30.31% | -38.75% | +8.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.64% | 25.28% | -1.64% |
Volatility
CALM vs. BSX - Volatility Comparison
The current volatility for Cal-Maine Foods, Inc. (CALM) is 7.03%, while Boston Scientific Corporation (BSX) has a volatility of 16.42%. This indicates that CALM experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CALM | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.03% | 16.42% | -9.39% |
Volatility (6M)Calculated over the trailing 6-month period | 20.18% | 32.93% | -12.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.13% | 34.80% | -1.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.59% | 25.67% | +6.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.16% | 27.29% | +3.87% |
Dividends
CALM vs. BSX - Dividend Comparison
CALM's dividend yield for the trailing twelve months is around 6.29%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CALM Cal-Maine Foods, Inc. | 6.29% | 10.90% | 2.82% | 7.51% | 3.17% | 0.09% | 0.00% | 0.98% | 1.03% | 0.00% | 2.70% | 4.10% |
Financials
CALM vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Cal-Maine Foods, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CALM vs. BSX - Profitability Comparison
CALM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported a gross profit of 119.28M and revenue of 666.95M. Therefore, the gross margin over that period was 17.9%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
CALM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported an operating income of 35.98M and revenue of 666.95M, resulting in an operating margin of 5.4%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
CALM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cal-Maine Foods, Inc. reported a net income of 50.46M and revenue of 666.95M, resulting in a net margin of 7.6%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
CALM and BSX have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (16.42%) compared to CALM (7.03%). In terms of maximum drawdown, CALM dropped -74.08% vs BSX's -89.15%.
CALM currently has the higher Sharpe Ratio (-0.55 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CALM and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer